China Underground > All the latest news about China > China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover raises $230 million, plans vaccines for COVID-19 variants

China’s Clover Biopharmaceuticals, a developer of coronavirus vaccines, has raised $230 million from investors, including Singapore’s state investment firm Temasek Holdings, it said on Tuesday, as it …

Previous

Canada’s Trudeau, Cabinet Abstain From China Genocide Vote

Hong Kong’s Carrie Lam defends China’s plans to ensure ‘patriots’ lead city

Next

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.